406 Patents
| Sl. No. | Title | Patent No | Brand /Ingredient |
| 1 | Curcuminoid composition and its therapuetic potential in managing lung fibrosis | US 11,491,119 | C3 Reduct® Special |
| 1 | Compositions and methods for beta secretase inhibition | US 11,458,117 | Sabroxy® |
| 2 | Method and composition for therapeutic management of gluten intolerance | US 11,419,906 | LactoSpore® |
| 3 | Compositions and methods for management of atrophic gastritis and colitis | US 11,413,318 | LactoSpore® |
| 4 | Plant actives and their anti-pollution effects thereof | US 11,351,102 | Sabroxy® + (THC / Pterostilbene / Resvenox®) |
| 5 | Alcoholic beverage composition containing Bacillus coagulans | US 11,332,702 | LactoSpore® |
| 6 | Microbial bioconversion of curcuminoids to Calebin-A | US 11,299,706 | Curcousin™ |
| 7 | Isolates from spent turmeric for the management of rheumatoid arthritis | US 11,298,395 | Starmeric® |
| 8 | Modulation of immune function by Bacillus coagulans | US 11,298,381 | Immunospore™ |
| 9 | Hypolipidemic effects of Bacillus coagulans | US 11,213,553 | LactoSpore® |
| 10 | Stable probiotic composition for the management of lactose intolerance | US 11,202,810 | LactoSpore® |
| 11 | Fructophilic lactic acid producing bacteria | US 11,197,898 | Fructospore® |
| 12 | Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans |
US 11,123,382 | LactoSporin® |
| 13 | Beverage compositions containing Bacillus coagulans MTCC 5856 | US 11,052,125 | LactoSpore® |
| 14 | Compositions for weight loss | US 11,052,125 | Cyperus + Forskolin + Garcinol |
| 15 | Composition for the therapeutic management of hypomelanotic skin conditions | US 11,045,517 | Forskolin + Nigellin® |
| 16 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 |
US 10,966,919 | LactoSporin® |
| 17 | Bioactive molecules from Oroxylum indicum and their therapeutic applications | US 10,959,980 | Sabroxy® |
| 18 | Compositions containing thymohydroquinone and their method of preparation | US 10,945,969 | Nigellin® |
| 19 | Method of inhibiting propionibacterium acnes | US 10,898,536 | Artocarpus |
| 20 | Neuroprotective compositions and their use | US 10,894,029 | Sabroxy® |
| 21 | Compositions for the management of hyperglycemia and related conditions | US 10,881,623 | Nigellin® |
| 22 | Composition for prostaglandin transporter inhibition and related therapeutic applications | US 10,864,243 | Sabeet® + Nigellin® + Arjuna + SelenoForce® |
| 23 | Aphrodisiac composition and management of male sexual dysfunction | US 10,864,242 | Xxtrastrong |
| 24 | Skin care compositions and their applications | US 10,864,154 | Ethyl ascorbic acid + THC |
| 25 | Compositions and methods for reducing flatulence | US 10,806,760 | LactoSpore® |
| 26 | Composition for management of Helicobacter pylori infection | US 10,792,295 | LactoSpore® + Saberry® |
| 27 | Adaptogenic compositions and applications thereof | US 10,716,823 | Polybos + Saberry® Polybos + Cococin™ |
| 28 | Stable probiotic composition containing Bacillus coagulans MTCC 5856 and method of detection thereof |
US 10,668,115 | LactoSpore® |
| 29 | Liver protectant compositions and therapeutic applications | US 10,653,643 | LivLonga® |
| 30 | Beverage compositions containing Bacillus coagulans MTCC 5856 | US 10,609,935 | LactoSpore® |
| 31 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof |
US 10,588,844 | Oletrip |
| 32 | Composition containing Oroxylin A and method of extraction thereof | US 10,555,982 | Oroxylin |
| 33 | Telomerase enhancement potential of Ecdysterone | US 10,548,902 | Ecdysterone |
| 34 | Functional nutritional blend for thermo-metabolic performance | US 10,477,886 | Metabolicgard |
| 35 | Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna |
US 10,479,749 | Arjunoglucoside |
| 36 | Process for the preparation of enantiopure 3-amino tetrahydrofuran and its salts | US 10,421,734 | 3-Amino Tetrahydrofurans |
| 37 | Process for synthesis of Oroxylin A | US 10,407,401 | Sabroxy® |
| 38 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
US 10,323,227 | LactoSpore® + Starmeric™ |
| 39 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
US 10,293,008 | LactoSpore® |
| 40 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 |
US 10,260,112 | LactoSpore® |
| 41 | Functional nutritional blend for thermo-metabolic performance | US 10,258,073 | Metabolicgard |
| 42 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 10,172,903 | Cyperus |
| 43 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | US 10,166,261 | LactoSpore® |
| 44 | Process and compositions for achieving mammalian energy balance | US 10,085,963 | Forskolin |
| 45 | Oleanoyl peptide composition and skin hydration | US 10,071,043 | Olepent® |
| 46 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene | US 9,913,809 | Zingiber cassumnar |
| 47 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene | US 9,833,422 | Zingiber cassumnar |
| 48 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9,782,450 | Cyperus |
| 49 | Calebin A for hepatic steatosis | US 9,737,502 | CurCousin™ |
| 50 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
US 9,717,766 | LactoSpore® + LactoCran™ |
| 51 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
US 9,681,666 | LactoSporin® + SabiLize® |
| 52 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
US 9,681,665 | LactoSporin® |
| 53 | Method for the treatment of hypercholesterolemia | US 9,668,999 | CurCousin™ |
| 54 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
US 9,635,862 | LactoSporin®, LactoSporin® + Sabilize® |
| 55 | Method for the treatment of hypercholesterolemia | US 9,610,273 | CurCousin™ |
| 56 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof |
US 9,596,861 | LactoSporin® |
| 57 | Process for the therapeutic management of Diarrhea predominant irritable bowel syndrome using Bacillus coagulans |
US 9,579,352 | LactoSpore® |
| 58 | Calebin A for osteoporosis | US 9,539,232 | CurCousin™ |
| 59 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | US 9,498,423 | Saberry® + Cococin™ + Se Peptide |
| 60 | Process for the manufacture of 3′-hydroxy pterostilbene | US 9,458,075 | 3-hydroxypterostilbene |
| 61 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | US 9,387,193 | Cyperus |
| 62 | Synthesis of Calebin A and its biologically active analogs | US 9,365,486 | CurCousin™ |
| 63 | Anti-obesity potential of Calebin A | US 9,328,330 | CurCousin™ |
| 64 | Composition and method for the protection of articular cartilage | US 9,220,703 | CurCousin™ |
| 65 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,056,074 | 3-hydroxypterostilbene |
| 66 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,050,284 | 3-hydroxypterostilbene |
| 67 | Synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 9,029,547 | Pharmaceutical Intermediates |
| 68 | Orally bioavailable stilbenoids-compositions and therapeutic applications thereof | US 9,029,424 | 3-hydroxypterostilbene |
| 69 | Oleanoyl peptide composition and method of treating skin aging | US 8,987,212 | Olepent® |
| 70 | Anti-obesity potential of Calebin A | US 8,933,121 | CurCousin™ |
| 71 | Novel synthesis of 4-aryl 4-acyl piperidine, its salts and analogs using indium metal | US 8,853,407 | Pharmaceutical intermediates |
| 72 | Inotilone derivatives as coherent biological response modifier (cBMR) | US 8,394,852 | Inotilone derivatives |
| 73 | Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals |
US 8,383,594 | Olepent® |
| 74 | Compositions and its use in treating obesity or inducing weight loss | US 8,329,743 | Livinol™+ Pterostilbene + Anthocyanin |
| 75 | Preservative system for cosmetic formulations—compositions and methods thereof | US 8,329,095 | SabiLize® |
| 76 | Protective compositions for dermal papilla cells | US 8,247,003 | Saberry® + Cococin™ |
| 77 | Dipeptides incorporating selenoamino acids with enhanced bioavailability–synthesis, pharmaceutical and cosmeceutical applications thereof |
US 8,193,156 | LSM-Dipeptide Synthetic route |
| 78 | Treatment of superficial and cutaneous mycoses with a pure form of 1,7-bis(4-hydroxy-3-methoxyphe nyl)-3,5-heptanedione |
US 8,119,696 | Tetrapure® |
| 79 | Dipeptides incorporating selenoaminoacids with enhanced bioavailability-synthesis | US 8,003,614 | MSC-Dipeptide Synthetic route |
| 80 | Hydro-alkoxyl citronellal compounds – synthetic routes, compositions and uses thereof | US 7,842,842 | Woody Odorants |
| 81 | Composition and methods for the management of hyperproliferative dermatological conditions | US 7,582,314 | Boswellin® |
| 82 | Novel non-cytotoxic synthetic analogues of (1E, 6E )-1,7-Bis (4 hydroxy-3-methoxyphenyl)-1,6-heptadiene-3, 5-dione and therapeutic applications thereof in cystic fibrosis |
US 7,521,580 | Curcuminoid analogs |
| 83 | Processes for the manufacture of chiral and racemic forms of 3-aminotetrahydrofurans, their salts and derivatives |
US 7,514,573 | 3-Aminotetrahydrofurans |
| 84 | Convenient process of manufacture for Difluoromethylornithine and related compounds | US 7,345,196 | Efflornithine |
| 85 | Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance |
US 7,300,682 | Cococin™ |
| 86 | Process for the synthesis of biologically active oxygenated compounds by dealkylation of the corresponding alkylethers |
US 7,253,324 | Stilbenes |
| 87 | Commercially viable process for high purity of fatty alcohol C24 to C36 and its cosmetic application for skin hair and nails |
US 7,217,546 | Policosanol |
| 88 | Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: Process for their manufacture and Uses |
US 7,202,270 | Liposol® |
| 89 | Bioavailable composition of natural and synthetic HCA | US 7,063,861 | GarCitrin® |
| 90 | Compositions and methods containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation |
US 7,014,874 | SelenoForce® |
| 91 | Convenient process of manufacture for Difluoromethylornithine and related compounds | US 6,998,502 | Efflornithine |
| 92 | Compositions and methods containing bioavailable Se-methyl-L-selenocysteine for human and veterinary use |
US 6,982,273 | Methyselene® (MSC) |
| 93 | Process for preparing water soluble diterpenes and their applications | US 6,960,300 | Ocufors® |
| 94 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
US 6,849,645 | Cosmoperine® (THP) |
| 95 | Manufacturing processes for Se-methyl-selenocysteine | US 6,794,537 | Methyselene® (MSC) |
| 96 | Process of obtaining compositions of stable lutein and lutein derivatives | US 6,689,400 | ZeaLutein® |
| 97 | Composition and methods containing an antimicrobial essential oil extracted from Coleus forskohlii | US 6,607,712 | Coleus Oil |
| 98 | Composition and method containing products extracted from commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease | US 6,436,991 | Gugulipid® |
| 99 | New Chemical entities with multiple modes of anti-inflammatory action | US 7,378,442 | AKBBA+NSAIDS |
| 100 | New chemical entities with multiple modes of anti-inflammatory action | US 7,371,889 | AKBBA+NSAIDS |
| 101 | Compositions and methods containing natural compounds from nonconventional sources that are useful in maintaining normal blood sugar levels | US 7,160,562 | Metformin-like compounds |
| 102 | Process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid | US 6,770,782 | Citrin® K |
| 103 | Cross regulin composition of turmeric-derived Tetrahydrocurcuminoids for skin lightening and protection against UVB rays | US 6,653,327 | Tetrahydrocurcuminoids |
| 104 | Process for making high purity piperine for nutritional use | US 6,054,585 | BioPerine® |
| 105 | Use of piperine as a bioavailability enhancer | US 5,972,382 | BioPerine® |
| 106 | Bioprotectant composition, method of use and extraction process of curcuminoids | US 5,861,415 | Curcumin C3 Complex® |
| 107 | Method of preparing a forskolin composition from forskolin extract and use of forskolin for promoting lean body mass and treating mood disorders | US 5,804,596 | ForsLean® |
| 108 | Potassium hydroxycitrate for the suppression of appetite and induction of weight loss | US 5,783,603 | Citrin® K |
| 109 | Use of piperine as a bioavailability enhancer | US 5,744,161 | BioPerine® |
| 110 | Use of piperine to increase bioavailability of nutritional compounds | US 5,536,506 | BioPerine® |
- UAE1
- Australia35
- Canada28
- China8
- DPR Korea1
- Eurasia12
- Europe30
- Germany1
- Great Britain1
- Hong Kong10
- India4
- Indonesia10
- Japan39
- Malaysia11
- Mexico6
- New Zealand26
- Philippines8
- Republic of Korea20
- Russia11
- Singapore10
- South Africa11
- Taiwan2
- Uzbekistan1
- Vietnam2
| Sl. No. | Title | Patent No | Brand /Ingredient |
| 285 | Compositions and methods for the management of hyperproliferative dermatological conditions | United Arab Emirates AE3178 |
Boswellin® |
| 1 | Compositions for the management of hyperglycemia and related conditions | Australia AU2018397668 |
Nigellin® |
| 1 | Spent turmeric- methods and compositions thereof | Australia AU2018307222 |
Starmeric® |
| 2 | Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | Australia AU2018290219 |
Arjuna |
| 3 | Skin care applications of extracellular metabolites from Bacillus coagulans | Australia AU2018282067 |
LactoSporin® |
| 4 | Compositions for management of Helicobacter pylori infections | Australia AU2018281141 |
LactoSpore® + Saberry® |
| 5 | Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Australia AU2006235807 |
Curcumin C3 Reduct® |
| 6 | Compositions containing thymohydroquinone and their method of preparation | Australia AU2018397667 |
Nigellin® |
| 7 | Alcoholic beverage composition containing Bacillus coagulans | Australia AU2018337853 |
LactoSpore® |
| 8 | Compositions and methods for reducing flatulence | Australia AU2018282018 |
LactoSpore® |
| 9 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Australia AU2018282252 |
LactoSporin® |
| 10 | Enzyme composition for therapeutic management of muscle soreness | Australia AU2016428484 |
DigeZyme® |
| 11 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Australia AU2016413572 |
LactoSpore® |
| 12 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2015394033 |
Cyperus |
| 13 | Oleanoyl peptide compositions and collagen enhancement | Australia AU2015381703 |
Olepent® |
| 14 | Bioavailable composition of natural and synthetic HCA | Australia AU773081 |
GarCitrin® |
| 15 | Compositions and methods for the management of hyperproliferative dermatological conditions | Australia AU2004322710 |
Boswellin® |
| 16 | Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Australia AU2006321973 |
SelenoForce® |
| 17 | Process for preparing water soluble diterpenes and their applications | Australia AU2004272005 |
Ocufors® |
| 18 | Anti-obesity potential of Calebin A | Australia AU2012366253 |
CurCousin™ |
| 19 | Hepatoprotectant activity of garcinol | Australia AU2011352073 |
Livinol™ |
| 20 | Composition for down-regulating pro-inflammatory markers | Australia AU2011200854 |
Boswellin® PS |
| 21 | Protective compositions for dermal papilla cells | Australia AU2010326651 |
Saberry® + Cococin™ |
| 22 | Oleanoyl peptide composition and a method of treating skin aging | Australia AU2011265587 |
Olepent® |
| 23 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Australia AU2014369819 |
LactoSporin® |
| 24 | Method for the treatment of hypercholesterolemia | Australia AU2014202312 |
CurCousin™ |
| 25 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Australia AU2012203148 |
Saberry® + Cococin™+ Se Peptide |
| 26 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Australia AU2015308650 |
LactoSpore® |
| 27 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Australia AU2013292593 |
Cyperus |
| 28 | Composition and method for the protection of articular cartilage | Australia AU2014201769 |
CurCousin™ |
| 29 | Anti-obesity potential of Calebin A | Australia AU2014203122 |
CurCousin™ |
| 30 | Process and compositions for achieving mammalian energy balance | Australia AU2015351423 |
Forskolin |
| 31 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl) butadiene | Australia AU2016385393 |
Zingiber cassumnar |
| 32 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Australia AU2018335280 |
LactoSporin® |
| 33 | Synthesis of Calebin A and its biologically active analogs | Australia AU2014203764 |
CurCousin™ |
| 34 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Australia AU2017228561 |
LactoSporin® |
| 35 | Alcoholic beverage composition containing Bacillus coagulans | Canada CA3075642 |
LactoSpore® |
| 36 | Anti-pollution compositions containing Bacillus coagulans | Canada CA3074267 |
LactoSpore® |
| 37 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Canada CA3064939 |
LactoSporin® |
| 38 | Adaptogenic compositions and applications thereof | Canada CA3014238 |
Boswellin® PS + Saberry® / Cococin™ |
| 39 | Use of piperine as a bioavailability enhancer | Canada CA2247467 |
BioPerine® |
| 40 | Forskolin for promoting lean body mass | Canada CA2281562 |
ForsLean® |
| 41 | Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Canada CA3047702 |
Artocarpus hirsutus |
| 42 | Composition containing Oroxylin A and method of extraction thereof | Canada CA3043168 |
Sabroxy® |
| 43 | Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof | Canada CA3047701 |
Artocarpus hirsutus |
| 44 | Bacillus coagulans MTCC 5856 For The Management Of Major Depressive Disorder | Canada CA3023818 |
LactoSpore® |
| 45 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Canada CA2999517 |
LactoSpore® |
| 46 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Canada CA2967952 |
LactoSpore® |
| 47 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Canada CA2883176 |
Cyperus |
| 48 | Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins | Canada CA2537820 |
Ocufors® |
| 49 | Anti-obesity Potential of Calebin A | Canada CA2857543 |
CurCousin™ |
| 50 | Composition for down-regulating pro-inflammatory markers | Canada CA2732915 |
Boswellin® PS |
| 51 | Hepatoprotectant activity of garcinol | Canada CA2851663 |
Livinol™ |
| 52 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Canada CA2872535 |
Saberry® + Cococin™+ Se Peptide |
| 53 | Method for the treatment of hypercholesterolemia | Canada CA2850999 |
CurCousin™ |
| 54 | Synthesis of Calebin A and its biologically active analogs | Canada CA2858126 |
CurCousin™ |
| 55 | Calebin A for hepatic steatosis | Canada CA2893321 |
CurCousin™ |
| 56 | Composition and method for the protection of articular cartilage | Canada CA2935898 |
CurCousin™ |
| 57 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Canada CA2899511 |
LactoSporin®, LactoSporin® + Sabilize® |
| 58 | Method for the treatment of hypercholesterolemia | Canada CA2963383 |
CurCousin™ |
| 59 | Calebin A for osteoporosis | Canada CA2941050 |
CurCousin™ |
| 60 | Oleanoyl peptide composition and collagen enhancement | Canada CA2975170 |
Olepent® |
| 61 | Method to solubilize curcuminoids in water | Canada CA2976689 |
uC3 CLEAR® |
| 62 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene | Canada CA2979287 |
Zingiber cassumnar |
| 63 | Method for the treatment of hypercholesterolemia | Taiwan I622384 |
CurCousin™ |
| 64 | Composition for down-regulating pro-inflammatory markers | Taiwan I-434696 |
Boswellin® PS |
| 65 | Method of enhancing the viable counts of lactic acid bacteria and method of producing short chain fatty acids | Vietnam VN33287 |
LactoSpore® |
| 66 | Method of solubilising forskolin and isoforskolin in water and clear aqueous solution comprising the same | Vietnam 12717 |
Ocufors® |
| 67 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Germany DE10196213 |
Cosmoperine® |
| 68 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 | Hong kong HK1240122 |
LactoSpore® |
| 69 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Hong kong HK1232483 |
Cyperus |
| 70 | Process and compositions for achieving mammalian energy balance | Hong kong HK1238675 |
Forskolin |
| 71 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Hong kong HK1233174 |
LactoSpore® |
| 72 | Synthesis of Calebin A and its biologically active analogs | Hong kong HK1217689 |
CurCousin™ |
| 73 | Process for preparing water soluble diterpenes and their applications | Hong kong HK1098450 |
Ocufors® |
| 74 | Method for the treatment of hypercholesterolemia | Hong kong HK1210590 |
CurCousin™ |
| 75 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Hong kong HK1193758 |
Saberry®+ Cococin™ + Se Peptide |
| 76 | Calebin A for articular cartilage | Hong kong HK1210028 |
CurCousin™ |
| 77 | Calebin A for use in the treatment of Inflammation and obesity | Hong kong HK1190874 |
CurCousin™ |
| 1 | Composition containing Oroxylin A and method of extraction thereof | China ZL201780070049.6 |
Sabroxy® |
| 78 | Process and compositions for achieving mammalian energy balance | China ZL201580083933.4 |
Forskolin |
| 79 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | China ZL201680008035.7 |
LactoSpore® |
| 80 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | China ZL201580042813.X |
LactoSpore® |
| 81 | Process For Preparing Water Soluble Diterpenes And Their Applications | China ZL200480028804.7 |
Ocufors® |
| 82 | Compositions and methods for the management of hyperproliferative dermatological conditions | China ZL200480043675.9 |
Boswellin® |
| 83 | Anti-obesity potential of Calebin A | China ZL201280012577.3 |
CurCousin™ |
| 84 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | China ZL201480010615.0 |
LactoSporin®, LactoSporin® + Sabilize® |
| 85 | Melanogenesis inhibition by 3,5-dimethoxy-4′-hydroxypterostilbenes and cosmeceutical applications thereof | DPR Korea 1011504 |
PteroWhite® |
| 86 | Use of piperine as a bioavailability enhancer | Europe EP0810868 |
BioPerine® |
| 87 | Bioprotectant composition, method of use and extraction process of curcuminoids | Europe EP0839037 |
Curcumin C3 Complex® |
| 88 | Forskolin for promoting lean body mass | Europe EP0977564 |
ForsLean® |
| 89 | Neuroprotective compositions and their use | Europe EP3638278 |
Sabroxy® |
| 90 | Enzyme composition for therapeutic management of muscle soreness | Europe EP3534934 |
DigeZyme® |
| 91 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Europe EP3478304 |
LactoSpore® |
| 92 | Adaptogenic compositions and applications thereof | Europe EP3419640 |
Polybos |
| 93 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Europe EP3356545 |
LactoSpore® |
| 94 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP3291805 |
Cyperus |
| 95 | Coconut water and its method of preparation | Europe EP1341547 |
Cococin™ |
| 96 | Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells | Europe EP1328263 |
Curcumin C3 Reduct® |
| 97 | Bioavailable composition of natural and synthetic HCA | Europe EP1254209 |
Garcitrin® |
| 98 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Europe EP3240553 |
LactoSpore® |
| 99 | Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Europe EP1171144 |
Curcumin C3 Reduct® |
| 100 | Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Europe EP1968620 |
SelenoForce® |
| 101 | Process for preparing water soluble diterpenes and their applications | Europe EP1718568 |
Ocufors® |
| 102 | Compositions and methods for the management of hyperproliferative dermatological conditions | Europe EP1791423 |
Boswellin® |
| 103 | Hepatoprotectant activity of garcinol | Europe EP2658374 |
Livinol™ |
| 104 | Protective compositions for dermal papilla cells | Europe EP2461786 |
Saberry® + Cococin™ |
| 105 | Method for the treatment of hypercholesterolemia | Europe EP2937084 |
CurCousin™ |
| 106 | Calebin A for use in the treatment of inflammation and obesity | Europe EP2663185 |
CurCousin™ |
| 107 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Europe EP2695603 |
Saberry® + Cococin™ + Se Peptide |
| 108 | Composition and method for the protection of articular cartilage | Europe EP2893926 |
CurCousin™ |
| 109 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Europe EP2989197 |
LactoSporin® |
| 110 | Calebin A for inducing lipolysis | Europe EP3085370 |
CurCousin™ |
| 111 | Synthesis of Calebin A and its biologically active analogs | Europe EP2963007 |
CurCousin™ |
| 112 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP2744571 |
Cyperus |
| 113 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Europe EP3108935 |
Cyperus |
| 114 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Europe EP3185877 |
LactoSpore® |
| 115 | Process and composition for achieving mammalian energy balance | Europe EP3194575 |
Forskolin |
| 116 | Skin care compositions and their applications | India IN356811 |
Ethyl Asccorbic acid + Sabiwhite® |
| 117 | A method for solubilizing forskolin and a composition thereof | India IN235492 |
Ocufors® |
| 118 | A Process of preparing a synergistic composition for treating hyperproliferative dermatological condition | India IN238950 |
Boswellin® |
| 119 | A process for obtaining high purity fatty alcohols | India IN229695 |
Policosanol |
| 120 | Hair care compositions containing extracellular metabolite preparation from bacillus coagulanstd> | Japan JP7150753 |
LactoSporin® |
| 121 | Alcoholic beverage composition containing bacillus coagulans | Japan JP7135079 |
LactoSpore® |
| 122 | Compositions containing thymohydroquinone and their method of preparation | Japan JP7089033 |
Nigellin® |
| 123 | Process for the preparation of standardized composition of arjunoglucoside from the bark of Terminalia arjuna | Japan JP7083215 |
Arjuna |
| 124 | Beverage compositions containing Bacillus coagulans MTCC 5856 | Japan JP7076148 |
LactoSpore® |
| 125 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Japan JP7039626 |
LactoSporin® |
| 126 | Compositions for the management of hyperglycemia and related conditions | Japan JP7012857 |
Nigellin® |
| 127 | Compositions and methods for reducing flatulence | Japan JP6987888 |
LactoSpore® |
| 128 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Japan JP6979518 |
Oletrip |
| 129 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Japan JP6938479 |
LactoSpore® |
| 130 | Use of Piperine as a bioavailability enhancer | Japan JP3953513 |
BioPerine® |
| 131 | Novel method for extraction of Oxyresveratrol from Artocarpus hirsutus | Japan JP6920462 |
Artocarpus hirsutus |
| 132 | Skin care applications of extracellular metabolites from Bacillus coagulans | Japan JP6918988 |
LactoSporin® |
| 133 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Japan JP6908633 |
LactoSpore® |
| 134 | Natural molecules from Artocarpus hirsutus: Method of isolation and anti-acne potential thereof | Japan JP6896885 |
Artocarpus hirsutus |
| 135 | Enzyme composition for therapeutic management of muscle soreness | Japan JP6857240 |
DigeZyme® |
| 136 | Composition containing Oroxylin A and method of extraction thereof | Japan JP6851476 |
Sabroxy® |
| 137 | Composition for management of Helicobacter pylori infection | Japan JP6839329 |
LactoSpore® + Saberry® |
| 138 | Neuroprotective compositions and their use | Japan JP6796217 |
Sabroxy® |
| 139 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6759243 |
Cyperus |
| 140 | Process of obtaining compositions of stable Lutein and Lutein derivatives | Japan JP4227409 |
Xenogard® |
| 141 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Japan JP4098985 |
Cosmoperine® |
| 142 | Bio-available compositions of natural and synthetic HCA | Japan JP4205943 |
GarCitrin® |
| 143 | Compositions and methods for the management of hyper-proliferative dermatological conditions | Japan JP4820819 |
Boswellin® |
| 144 | Process for preparing water soluble diterpenes and their applications | Japan JP5021305 |
Ocufors® |
| 145 | Hepatoprotectant activity of garcinol | Japan JP5980228 |
Livinol™ |
| 146 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Japan JP6064274 |
Saberry® + Cococin™ + Se Peptide |
| 147 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Japan JP6126307 |
LactoSporin®, LactoSporin® + Sabilize® |
| 148 | Scirpusin A and Scirpusin B and anti-obesity potential thereof | Japan JP6135761 |
Cyperus |
| 149 | Composition and method for the protection of articular cartilage | Japan JP6142446 |
CurCousin™ |
| 150 | Calebin A for hepatic steatosis | Japan JP6336943 |
CurCousin™ |
| 151 | Oleanoyl peptide composition and a method of treating skin aging | Japan JP6176893 |
Olepent® |
| 152 | Method for the treatment of hypercholesterolemia | Japan JP6263707 |
CurCousin™ |
| 153 | Anti-obesity potential of Calebin A | Japan JP6374716 |
CurCousin™ |
| 154 | Process and compositions for achieving mammalian energy balance | Japan JP6472453 |
Forskolin |
| 155 | Synthesis of Calebin A and its biologically active analogs | Japan JP6490927 |
CurCousin™ |
| 156 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene | Japan JP6584526 |
Zingiber cassumnar |
| 157 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Japan JP6629875 |
LactoSpore® |
| 158 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Japan JP6630723 |
LactoSpore® |
| 159 | Process and compositions for achieving mammalian energy balance | Japan JP7012857 |
Nigellin® |
| 160 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Mexico MX389328 |
Forskolin |
| 161 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Mexico MX376004 |
LactoSpore® |
| 162 | Process for preparing water soluble diterpenes and their applications | Mexico MX260326 |
Ocufors® |
| 163 | Composition for down-regulating pro-inflammatory markers | Mexico MX328842 |
Boswellin® PS |
| 164 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Mexico MX355546 |
Saberry® + Cococin™ +Se Peptide |
| 165 | Adaptogenic compositions and applications thereof | Malaysia MY-189911-A |
Polybos |
| 166 | Process and compositions for achieving mammalian energy balance | Malaysia MY-188869-A |
Forskolin |
| 167 | Oleanoyl peptide composition and collagen enhancement | Mexico MY-188723-A |
Olepent® |
| 168 | Novel PCR primers and methods thereof for the identification of Bacillus coagulans MTCC 5856 | Malaysia MY-185340-A |
LactoSpore® |
| 169 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Malaysia MY-182658-A |
LactoSpore® |
| 170 | Calebin A for hepatic steatosis | Malaysia MY-182000-A |
CurCousin™ |
| 171 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Malaysia MY-181102-A |
LactoSporin® |
| 172 | Compositions and method for the protection of articular cartilage | Malaysia MY-175867-A |
CurCousin™ |
| 173 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Malaysia MY-168089-A |
Saberry® + Cococin™ +Se Peptide |
| 174 | Method for the treatment of hypercholesterolemia | Malaysia MY-170067-A |
CurCousin™ |
| 175 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Malaysia MY-174855-A |
LactoSpore® |
| 1 | Compositions and methods for reducing flatulence | New Zealand NZ759306 |
LactoSpore® |
| 176 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Newzealand NZ732234 |
LactoSpore® |
| 177 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Newzealand NZ748360 |
LactoSpore® |
| 178 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Newzealand NZ748553 |
LactoSpore® |
| 179 | Composition containing Oroxylin A and method of extraction thereof | Newzealand NZ753943 |
Sabroxy® |
| 180 | Enzyme composition for therapeutic management of muscle soreness | Newzealand NZ752952 |
DigeZyme® |
| 181 | Composition for physiological increase of male and female hormones with diterpene forskolin and its derivatives | Newzealand NZ552997 |
Forskolin |
| 182 | Compositions and methods for the management of hyperproliferative dermatological conditions | Newzealand NZ552027 |
Boswellin® |
| 183 | Commercial process for making forskolin and its derivatives | Newzealand NZ568652 |
Ocufors® |
| 184 | Process for preparing water soluble diterpenes and their applications | Newzealand NZ545765 |
Ocufors® |
| 185 | Bioavailable composition of natural and synthetic HCA | Newzealand NZ518116 |
GarCitrin® |
| 186 | Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa | Newzealand NZ514884 |
Curcumin C3 Reduct® |
| 187 | Compositions containing Allium sativum Linn. (garlic) naturally enriched with organic selenium compounds for nutritional supplementation | Newzealand NZ568233 |
SelenoForce® |
| 188 | Protective compositions for dermal papilla cells | Newzealand NZ598630 |
Saberry®+ Cococin™ |
| 189 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Newzealand NZ600307 |
Saberry®+ Cococin™ + Se dipeptide |
| 190 | Method for the treatment of hypercholesterolemia | Newzealand NZ624269 |
CurCousin™ |
| 191 | Hepatoprotectant activity of garcinol | Newzealand NZ609878 |
Livinol™ |
| 192 | Anti-obesity potential of Calebin A | Newzealand NZ614076 |
CurCousin™ |
| 193 | Synthesis of Calebin A and its biologically active analogs | Newzealand NZ627247 |
CurCousin™ |
| 194 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Newzealand NZ622927 |
Cyperus |
| 195 | Anti-obesity potential of calebin A | Newzealand NZ715053 |
CurCousin™ |
| 196 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Newzealand NZ711345 |
LactoSporin®, LactoSporin® + Sabilize® |
| 197 | Composition and method for the protection of articular cartilage | Newzealand NZ622909 |
CurCousin™ |
| 198 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene | Newzealand NZ735027 |
Zingiber cassumnar |
| 199 | Method to solubilize curcuminoids in water | Newzealand NZ734491 |
UC3 clear® |
| 200 | Process and compositions for achieving mammalian energy balance | Newzealand NZ720422 |
Forskolin |
| 201 | Anti-pollution compositions containing Bacillus coagulans | Russia RU2745755 |
LactoSpore® |
| 202 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Russia RU2733372 |
Oletrip |
| 203 | Compositions and methods for the management of hyperproliferative dermatological conditions | Russia RU2366412 |
Boswellin® |
| 204 | Anti-obesity potential of Calebin A | Russia RU2543334 |
CurCousin™ |
| 205 | Hepatoprotectant activity of garcinol | Russia RU2585245 |
Livinol™ |
| 206 | Synergistic selenopeptide formulations for the protection of dermal papilla cells | Russia RU2606752 |
Saberry® + Cococin™ + Se Peptide |
| 207 | Calebin A for hepatic steatosis | Russia RU2643297 |
CurCousin™ |
| 208 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Russia RU2617965 |
LactoSporin®, LactoSporin® + Sabilize® |
| 209 | Calebin A for osteoporosis | Russia RU2653103 |
CurCousin™ |
| 220 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene | Russia RU2694053 |
Zingiber cassumnar |
| 211 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Russia RU2691404 |
Cyperus |
| 212 | Anti-cancer activity of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene | Singapore SG11201707112P |
Zingiber cassumnar |
| 213 | Process and compositions for achieving mammalian energy balance | Singapore SG11201801873T |
Forskolin |
| 214 | Process for preparing water soluble diterpenes and their applications | Singapore SG121197 |
Ocufors® |
| 215 | Compositions and methods for the management of hyperproliferative dermatological conditions | Singapore SG136165 |
Boswellin® |
| 216 | Calebin A for hepatic steatosis | Singapore SG10201503805X |
CurCousin™ |
| 217 | Composition and methods for the protection of articular cartilage | Singapore SG11201605336Y |
CurCousin™ |
| 218 | Anti-obesity potential of calebin A | Singapore SG192695 |
CurCousin™ |
| 219 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Singapore SG11201505628P |
LactoSporin®, LactoSporin® + Sabilize® |
| 220 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Singapore SG11201700006U |
LactoSpore® |
| 221 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Singapore SG11201707106U |
Cyperus |
| 222 | Liver protectant composition and therapeutic applications | South Africa ZA2020/06540 |
LivLonga® |
| 223 | Modulation of immune function by Bacillus coagulans | South Africa ZA2020/07348 |
Immunospore |
| 224 | Skin care compositions and their applications | South Africa ZA2020/06708 |
Ethyl Ascorbic Acid + SabiWhite® |
| 225 | Compositions for the management of hyperglycemia and related conditions | South Africa ZA2020/04532 |
Nigellin® |
| 226 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | South Africa ZA2019/00501 |
LactoSpore® |
| 227 | Enzyme composition for maintenance of metabolic health | South Africa 2019/07676 |
DigeZyme® |
| 228 | Composition and methods for the management of hyperproliferative dermatological Conditions | South Africa ZA2007/0694 |
Boswellin® |
| 229 | Process for preparing water soluble diterpenes and their applications | South Africa ZA2006/01898 |
Ocufors® |
| 230 | Anti-obesity potential of Calebin A | South Africa ZA2013/05918 |
CurCousin™ |
| 231 | Method to solubilize curcuminoids in water | South Africa ZA2017/06503 |
UC3 Clear® |
| 232 | Enzyme composition for therapeutic management of muscle soreness | South Africa ZA2019/02715 |
DigeZyme® |
| 233 | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives | Great Britain GB2380675 |
Cosmoperine® |
| 234 | Process for preparing water soluble diterpenes and their application | Uzbekistan 4028 |
Ocufors® |
| 235 | Process and composition for achieving mammalian energy balance | Eurasia EA38685 |
Forskolin |
| 236 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 | Eurasia EA037312 |
LactoSpore® |
| 237 | Process for preparing water soluble diterpenes and their applications | Eurasia EA012836 |
Ocufors® |
| 238 | Bacillus coagulans MTCC 5856 for the management of major depressive disorder | Eurasia EA038255 |
LactoSpore® |
| 239 | Protective compositions for dermal papilla cells | Eurasia EA20368 |
Saberry® + Cococin™ |
| 240 | Use of a composition for down-regulating/inhibiting PGE2 | Eurasia EA023717 |
Boswellin® PS |
| 241 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Eurasia EA025578 |
Cyperus |
| 242 | Method for the treatment of hypercholesterolemia | Eurasia EA027148 |
CurCousin™ |
| 243 | Use of calebin A to protect mammalian articular cartilage from pathological damage | Eurasia EA027614 |
CurCousin™ |
| 244 | Synthesis of calebin A and its biologically active analogs | Eurasia EA027726 |
CurCousin™ |
| 245 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Eurasia EA034017 |
LactoSpore® |
| 246 | Oleanoyl peptide composition and collagen enhancement | Eurasia EA03512 |
Olepent® |
| 247 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus coagulans SBC37-01, MTCC 5856 | Philippines PH1-2017-50132 |
LactoSpore® |
| 248 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Philippines PH1-2017-500059 |
LactoSpore® |
| 249 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Philippines PH1-2015-500349 |
Cyperus |
| 250 | Process for preparing water soluble diterpenes and their applications | Philippines PH1-2006-500481 |
Ocufors® |
| 251 | Method for the treatment of hypercholesterolemia | Philippines PH1-2014-000244 |
CurCousin™ |
| 252 | Calebin A for hepatic steatosis | Philippines PH1-2015-000188 |
CurCousin™ |
| 253 | Composition and method for the protection of articular cartilage | Philippines PH1-2016-501138 |
CurCousin™ |
| 254 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Philippines PH1-2015-502025 |
LactoSporin®, LactoSporin® + Sabilize® |
| 255 | Compositions and methods for reducing flatulence | Republic of Korea KR10-2452792 |
LactoSpore®td> |
| 256 | Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof | Republic of Korea KR10-2412222 |
Oletrip |
| 257 | Compositions for management of Helicobacter pylori infections | Republic of Korea KR10-2403453 |
LactoSpore® + Saberry® |
| 258 | Anti-pollution compositions containing Bacillus coagulans | Republic of Korea KR10-2376076 |
LactoSpore® |
| 259 | Skin care applications of extracellular metabolites from Bacillus coagulans | Republic of Korea KR10-2296051 |
LactoSporin® |
| 260 | Anti-obesity potential of garcinol | Republic of Korea KR10-2289324 |
Garcinol |
| 261 | Anti-aging potential of extracellular metabolite isolated from Bacillus coagulans MTCC 5856 | Republic of Korea KR10-2288904 |
LactoSporin® |
| 262 | Hair care compositions containing extracellular metabolite preparation from Bacillus coagulans | Republic of Korea KR10-2288897 |
LactoSporin® |
| 263 | Process and compositions for achieving mammalian energy balance | Republic of Korea KR10-2169620 |
Forskolin |
| 264 | Process for the therapeutic management of diarrhea predominant irritable bowel syndrome using Bacillus Coagulans SBC37-01, MTCC 5856 | Republic of Korea KR10-2157043 |
LactoSpore® |
| 265 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Republic of Korea KR10-1600212 |
Cyperus |
| 266 | Synthesis of Calebin A and its biologically active analogs | Republic of Korea KR10-1629561 |
CurCousin™ |
| 267 | Method for the treatment of hypercholesterolemia | Republic of Korea KR10-1647549 |
CurCousin™ |
| 268 | Composition and method for the protection of articular cartilage | Republic of Korea KR10-1685263 |
CurCousin™ |
| 269 | Composition and method for the protection of articular cartilage | Republic of Korea KR10-1685333 |
CurCousin™ |
| 270 | Anti-obesity potential of Calebin A | Republic of Korea KR10-1702702 |
CurCousin™ |
| 271 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Republic of Korea KR10-1717889 |
Cyperus |
| 272 | Calebin A for hepatic steatosis | Republic of Korea KR10-1763474 |
CurCousin™ |
| 273 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Republic of Korea KR 10-1770902 |
LactoSporin®, LactoSporin® + Sabilize® |
| 274 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Republic of Korea KR10-2089566 |
LactoSpore® |
| 275 | Oleanoyl peptide composition and collagen enhancement | Indonesia IDP000074771 |
Olepent® |
| 276 | Novel pcr primers and methods thereof for the identification of Bacillus coagulans | Indonesia IDP000074645 |
LactoSpore® |
| 277 | Composition comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Indonesia PID201708495 |
Cyperus |
| 278 | Process and compositions for achieving mammalian energy balance | Indonesia IDP000071226 |
ForsLean® |
| 279 | Calebin A for hepatic steatosis | Indonesia IDP000067993 |
CurCousin™ |
| 280 | Synergistic selenopeptide formulations for the protection of dermal papilla cell | Indonesia IDP000051688 |
Saberry® + Cococin™ + Se-dipeptide |
| 281 | Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof | Indonesia IDP00201506134 |
LactoSporin®, LactoSporin® + Sabilize® |
| 282 | Compositions comprising Scirpusin A and Scirpusin B and anti-obesity potential thereof | Indonesia IDP000062703 |
Cyperus |
| 283 | Calebin A and its effect on hypercholesterolemia | Indonesia IDP000064827 |
CurCousin™ |
| 284 | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof | Indonesia IDP000066793 |
LactoSpore® |
- Active
- Expired